Metabolic disorders during pregnancy and postpartum cardiometabolic risk. Issue 5 (May 2018)

• Record Type: Journal Article
• Authors: Patti, Angelo Maria; Pafili, Kalliopi; Papanas, Nikolaos; Rizzo, Manfredi
• Is Part Of: Endocrine connections. Volume 7:Issue 5(2018)
• Page Start: E1
• Page End: E4
• Publication Date: 2018-05
• Subjects: cardiovascular risk -- gestational diabetes -- hypertension -- metabolic syndrome; Endocrinology -- Periodicals; 616.4005
• DOI: 10.1530/EC-18-0130
• Languages: English
• ISSNs: 2049-3614

Abstract

Abstract : Hormonal changes during pregnancy can trigger gestational diabetes (GDM), which is constantly increasing. Its main characteristic is pronounced insulin resistance, but it appears to be a multifactorial process involving several metabolic factors; taken together, the latter leads to silent or clinically evident cardiovascular (CV) events. Insulin resistance and central adiposity are of crucial importance in the development of metabolic syndrome, and they appear to correlate with CV risk factors, including hypertension and atherogenic dyslipidaemia. Hypertensive disease of pregnancy (HDP) is more likely to be an accompanying co-morbidity in pregnancies complicated with GDM. There is still inconsistent evidence as to whether or not co-existent GDM and HDP have a synergistic effects on postpartum risk of cardiometabolic disease; however, this synergism is becoming more accepted since both these conditions may promote endothelial inflammation and early atherosclerosis. Regardless of the presence or absence of the synergism between GDM and HDP, these conditions need to be dealt early enough, in order to reduce CV morbidity and to improve health outcomes for both women and their offspring.